Timothy C Humphrey

6PUBLICATIONS
26CO-AUTHORS
Haematological tumoursCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 19, 2025
Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers.

Tomas Goncalves, Siobhan Cunniffe, Tiffany S Ma

|Feb 08, 2025
Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers.

Tomas Goncalves, Siobhan Cunniffe, Tiffany S Ma

|Mar 23, 2023
Homologous recombination suppresses transgenerational DNA end resection and chromosomal instability in fission yeast.

Chen-Chun Pai, Samuel C Durley, Wei-Chen Cheng

|Sep 20, 2021
Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring.

Jenny F Seligmann, David J Fisher, Louise C Brown

|Dec 01, 2020
The Challenge of Combining Chemo- and Radiotherapy with Checkpoint Kinase Inhibitors.

Linda van Bijsterveldt, Samuel C Durley, Tim S Maughan

|Jan 25, 2019
An essential role for dNTP homeostasis following CDK-induced replication stress.

Chen-Chun Pai, Kuo-Feng Hsu, Samuel C Durley

Pageof 1